. Together, these data suggest that EPRS phosphorylation by S6K1 plays a key part in regulating fat mass in mice, and that the absence of such phosphorylation might mediate the beneficial effects of S6K1 deletion on metabolism and ageing.
. It is surprising that the increased lifespan seen in S6K1-deficient mice can be mimicked by the mutation of a single serine residue in EPRS, given the many roles and substrates of S6K1. One potential explanation is that S6K1-deficient mice have a mixture of beneficial and detrimental traits, but the overarching output confers increased lifespan. In this scenario, the EPRS-dependent pathway might simply capture the beneficial effects. To bolster such an idea, it will be crucial to determine whether S999A mice show increased healthspan, in addition to increased lifespan. It will also be important to examine mice harbouring the S999D mutation in greater detail, because, surprisingly, these seem to lack traits that are associated with enhanced mTOR-S6K1 signalling in fat, such as insulin resistance and obesity.
The precise relationship between EPRS-and S6K1-dependent longevity could be further examined in genetic experiments using the mutants generated by Arif and colleagues. For example, is the increased longevity of S6K1-deficient mice abrogated by the S999D mutation, as would be expected if that longev ity is dependent on the absence of EPRS phosphoryl ation? Likewise, if S6K1 and EPRS act in a linear pathway, S6K1-deficient mice that have the S999A mutation should have no additional metabolic or lifespan benefits over S6K1-deficient mice that have wildtype EPRS. Such complex genetic studies would support the idea that EPRS is a key regulator of ageing in the mTOR pathway.
The authors suggest that the changes in metabolism and longevity seen in S999A mutants stem mainly from altered fat-tissue biology and are caused solely by a lack of S6K1-mediated phosphorylation. But reduced fat mass in S999A mutants begins in adulthood, whereas S6K1-deficient mice are lean at an earlier age, in part owing to defects in fat-cell development 9 -pointing to the possibility that EPRS acts through other mechanisms. Furthermore, mice lacking FATP1 do not show the reduced fat mass and increased insulin sensitivity seen in S999A mice 10 , hinting that EPRS also acts in other tissues. This idea is supported by the fact that S6K1 has roles in metabolic regulation in the liver, muscle and central nervous system 11, 12 . Specifically deleting S6K1 in fat and studying EPRS function in this tissue could provide further insight.
The excitement about the current study stems from the potential to target S6K1-EPRS signalling to treat metabolic disease and perhaps the pathology of ageing. Directly targeting Ser999 phosphorylation would be challenging, but it is well established that pharmacological blockade of mTOR-S6K1 signalling using the immunosuppressant drug rapamycin extends lifespan and increases healthspan in mice 13 . It would be useful to determine whether any of the effects of rapamycin are mediated by EPRS-dependent mechanisms, because this may help to refine strategies aimed at targeting the mTOR pathway.
Finally, it would be interesting to assess whether there are alterations in EPRS function in ageing humans, and whether genetic variation in EPRS contributes to differences in human lifespan. Only then will we know the full potential of Arif 
GENOMICS

Keen insights from quinoa
Technological advances have allowed scientists to sequence the complex quinoa genome. This highlights the ongoing expansion of genomics beyond major crops to other plants that have relevance for global food security. See Article p.307
, one of us estimated that, given ongoing technological advances, 200 domesticated plants would be sequenced within 14 years 1 . Genomics has already outstripped this prediction, with most major crop plants, domesticated animals and model organisms having now been sequenced. Nonetheless, the genomes of many organisms that are valuable to local communities and have potentially high salience to a world challenged by issues of food security remain to be tackled. One example of such an organism is the Andean crop quinoa (Chenopodium quinoa). On page 307, Jarvis et al. 2 report a high-quality genome sequence for this species. Archaeological evidence 3 indicates that quinoa was domesticated some 7,000 years ago in the high plateau around Lake Titicaca in the Andes (Fig. 1) , becoming a major food crop for Andean civilizations that preceded the Inca 3,4 . Quinoa was prized for its nutritional qualities and adaptability to diverse environments, growing at an exceptional range of altitudes (from sea level to 4 kilometres above it), temperatures (from −8 °C to 38 °C), humidities and soil conditions 5 . By the mid-twentieth century, quinoa had fallen out of fashion, being cultivated mainly by isolated native communities in the Andean highlands. It wasn't until the 1970s that the plant's nutritional and commercial potential began to be more widely appreciated 6 , but increased scientific input into breeding programmes will be needed if the full potential of this crop is to be realized.
With this aim in mind, Jarvis et al. sequenced the approximately 1.5-gigabase-long genome of C. quinoa. This species, like many plants, is polyploid -it has four copies of each of its nine chromosomes, because it arose by hybridization of two ancestral diploid species (which have two sets of chromosomes). The ancestors, dubbed A and B, each contributed two sets of nine chromosomes to the polyploid progeny. The authors used singlemolecule, real-time sequen cing in combination with a range of sophisticated mapping techniques to properly interleave other wiseisolated DNA sequences with one another.
This integration of sequencing and mapping techniques led to the assembly of 439 sequence 'scaffolds' that together covered 90% of the genome and that aligned into 18 groups, matching the 18 basal chromosomes (one set of 9 derived from each ancestor). This feat is particularly impressive given that, as the authors note, a remarkable 64% of the quinoa genome consists of repetitive DNA, making it challenging to find the islands of unique sequence that are necessary to piece together the jigsaw puzzle of its chromosomes.
A combination of transcript analysis and ab initio prediction (in which the genome is searched for sequences characteristic of genes) suggested that the genome contains 44,776 genes. Of an existing database of 956 known quinoa genes, 97.3% were found in the current sample, indicating that the sequence covers nearly the whole genome.
Next, the authors generated draft (less indepth) sequences for other members of the Chenopodium genus: 15 genetically different quinoa strains (accessions); five and two accessions, respectively, of polyploid relatives C. berlandieri and C. hircinum; and two diploid plants, C. pallidicaule and C. suecicum, which are descended, respectively, from the suspected A and B progenitors of quinoa. These data provided insight into the radiation and domestication of Chenopodium species.
Comparison with quinoa's two suspected diploid progenitors revealed that nine of the basal C. quinoa chromosomes more closely resemble the A genome progenitor C. pallidicaule, which derives from the New World. The other nine resemble the Eurasian B genome progenitor C. suecicum. These data provide further support for the existing theory 7 that the Eurasian progenitor dispersed across the ocean prior to formation of the polyploid C. quinoa, 3.3 million to 6.3 million years ago.
A constraint on the widespread acceptance of quinoa as a major crop for human consumption is the bitter-tasting compounds called saponins that coat quinoa seeds. These compounds deter pests, but destroy red blood cells and so must be removed before consumption -a process that uses waterand labour-intensive techniques. Certain 'sweet' quinoa lines produce very low levels of saponins. However, these strains are not yet widely cultivated in the Andes, at least in part because of increased predation by birds and other pests, which results in lower yields.
In their final experiments, Jarvis et al. identified a DNA sequence associated with the presence or absence of saponins. The candidate sequence is a small genomic region encoding two transcription factors that are involved in saponin biosynthesis. Only one of these, AUR62017204, is expressed in seeds, with its expression in sweet quinoa lines producing a truncated protein that presumably results in reduced saponin production.
The authors' genome sequence overcomes key obstacles to the study and use of quinoa, but challenges remain. For example, proof that an AUR62017204 variant confers 'sweetness' will require demonstration that introduction of this variant into wildtype quinoa reduces saponin production. Such introduction could be achieved either as part of an engineered genetic construct (which has not been done, to our knowledge) or by replacing the wild-type sequence with the sweet variant using genome editing (a possibility that involves some time and cost).
Using the information gained from the genome to improve quinoa production will require invigorated breeding efforts. Likewise, identification of the defences used by quinoa and other members of the Amaranthaceae family of plants to achieve stress tolerance in a range of environments will require much fundamental research. The transfer of these abiotic stress defences -or of other traits -from quinoa to other crops is an intriguing possibility, but far from trivial.
Nonetheless, the ability to rapidly gain insights into the biology and evolution of characteristics of interest in particular organisms will lead to new agricultural possibilities. For example, if diagnostic DNA markers for a trait of interest or genome editing can be used to speed up the breeding of commercially viable sweet quinoa varieties, it could provide an economic opportunity for farmers in the Andes and beyond, increasing food production in challenging environments. Sequencing the genomes of other neglected food crops 8 
DA R L E E N
or decades, it was thought that weightloss surgery was effective mainly because it led to a combination of gastric restriction and caloric malabsorption. However, it has become abundantly clear that there are more-complex explanations, which can be unpicked by examining how surgery alters communication between the gastrointestinal (GI) tract and other organs 1 . Writing in Cell Metabolism, Hankir et al. 2 describe their use of gastric-bypass surgery as a tool with which to identify the molecular underpinnings that link GI signals to changes in the central nervous system in rats. The study shines a light on one poorly understood effect of gastric bypass -changes in food choice.
In general, rodents given the choice between high-and low-fat foods prefer the high-fat options [3] [4] [5] . Gastric bypass reduces stomach size, and so it might be expected that animals would choose calorically dense foods such as fat after surgery. Instead, obese animals that have received surgery avoid these foods [3] [4] [5] . Thus, a major response to gastric bypass in rats is a profound change in the foods they prefer. These data underscore the fact that, although we sometimes feel as if our choice of food is a voluntary act driven by weaknesses in our character, signals from the GI tract probably affect how we interact with food in our environment.
What might be the pathways that mediate this change? In the gut, a fatty-acid derivative called oleoylethanolamide (OEA) is synthesized when fat is ingested, and activates intestinal PPAR-α receptors. It is thought that these receptors, in turn, activate the vagus nerve, which projects to the brain, to promote satiety 6 . In the brain, the release of the neurotransmitter molecule dopamine activates reward circuits, but release is suppressed in rats that are obese as a result of having been placed on a high-fat diet. Supplementing the rats' diets with OEA restores dopamine release from a brain region called the dorsal striatum and suppresses fat ingestion 7 . These data suggest that signalling from the GI tract to the dorsal striatum regulates fat preference.
Hankir et al. investigated whether this pathway might regulate the changes in feeding behaviour that are observed in rats following gastric bypass. OEA levels, like those of dopamine, are dampened in obese animals, and the authors observed that the surgery restored levels of OEA in the gut to pre-obesity levels. They found that, in animals that had undergone gastric bypass, striatal dopamine levels were increased compared with those in control animals that underwent a sham operation (in which the peritoneal cavity was opened but the GI tract was not surgically re arranged). As a second control, the researchers showed that dopamine levels in animals that had undergone surgery were also higher than in animals that had lost the same amount of weight through food restriction.
Next, Hankir and colleagues confirmed that gastric bypass results in a preference for low-over high-fat diets. This shift in preference could be blunted by blocking the ability of OEA to activate PPAR-α -by cutting the vagus nerve or by blocking dopamine signalling in the striatum. Together, the authors' data outline a pathway by which altered signalling between the GI tract and the brain leads to different food choices following gastric bypass (Fig. 1) .
The usual methods by which eating behaviour is assessed in humans outside laboratory conditions are fraught with error, owing to both conscious and unconscious under-reporting of food ingestion and an inability to control environmental contributions to eating 8 . After all, who wants a nutritionist to see what they really eat each day? Still, numerous reports demonstrate that both humans 9 and rodents 10,11 ingest smaller meals post-operatively, and that these effects are reflected in differences in brain activation in response to food. In humans, these effects are not just attributable to the post-operative dietary counselling that people receive 9 .
PHYSIOLOGY
Gut feeling for food choice
One effect of weight-loss surgery is a change in food preferences. An analysis in rats shows that this is caused by altered nutrient signals in the intestine. These activate the vagus nerve to increase signalling in the brain by the neurotransmitter dopamine. 2 report that gastric-bypass surgery leads to the production of the molecule oleoylethanolamide (OEA) in the gut. OEA activates the receptor protein PPAR-α, which activates the vagus nerve. This sends signals from the gut to the brain, leading to release of the neurotransmitter molecule dopamine from a brain region called the dorsal striatum, which is involved in reward. The authors show that activation of this pathway leads rats to choose low-fat over high-fat food, but whether this change is a driver of weight loss remains to be proved. 
